Superworth

Xencor profit margin XNCR

Gross, operating and net profit as a share of revenue over the last twelve months, from 2017.

Net margin, 12 months
n/m
not a meaningful number
Peer median
10.9%

Xencor's net margin works out at −156% over the last twelve months, but it is not a meaningful number: a margin outside minus 100% to 100% is moved by items that are not sales.

Profit margin over time

OperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating margin
FY2025−73.2%n/a
FY2024n/an/a
FY2023−74.9%−78.6%
FY2022−33.5%−50.1%
FY202130.0%15.9%
FY2020−56.5%−62.6%
FY201917.2%8.8%
FY2018n/an/a
FY2017−83.4%−93.4%
FY2016n/an/a
FY2015n/an/a
FY2014n/an/a
FY2013n/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26n/an/an/a
Q1 FY26n/an/an/a
Q4 FY25−73.2%n/an/a
Q3 FY25−87.1%n/a−91.3%
Q2 FY25n/an/a−98.5%
Q1 FY25n/an/an/a
Q4 FY24n/an/an/a
Q3 FY24n/an/an/a
Q2 FY24n/an/an/a
Q1 FY24−83.9%n/a−76.4%
Q4 FY23−74.9%−41.4 pts−78.6%
Q3 FY23−81.9%−92.0 ptsn/a

Against its peers

Companies in Drug Manufacturers - General nearest Xencor's size, closest first, today.

CompanyProfit margin
XNCRXencorn/m
ANIPANI Pharmaceuticals11.1%
HRMYHarmony Biosciences18.9%
PAHCPhibro Animal Health6.6%
PBHPrestige Consumer Healthcare15.6%
ANABAnaptysbion/m
PCRXPacira BioSciences2.0%
NRIXNurix Therapeutics42.0%
OMEROmerosn/m
AMPHAmphastar Pharmaceuticals10.8%
OGNOrganon3.4%
Peer median10.9%

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Xencor

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.